Decision Resources, Inc., today announced the availability of its new, proprietary decision support tool, COMPETITIVE LANDSCAPE ™ for CNS. Featuring robust and continually updated data and analyses, COMPETITIVE LANDSCAPE is a unique, Web-based multiclient service that provides objective analysis of the critical factors that drive a drug's clinical strength and commercial potential. In addition to highlighting and analyzing the competitive aspects of both CNS development candidates and key marketed drugs, COMPETITIVE LANDSCAPE provides valuable insight on potential licensing opportunities and pharmaceutical company CNS franchise strength.
(Photo: http://www.newscom.com/cgi-bin/prnh/20000303/DECISION ) Challenges to Maintaining Market Position
"In recent years, the CNS market has grown in complexity. Not only is the number of compounds in clinical development dramatically increasing, but the impending patent expirations of numerous blockbuster drugs are placing added pressure on pharmaceutical companies to 'fill the gaps' in their drug discovery pipelines," states Joe Walsh, Decision Resources' Vice President and Managing Director of North American Sales and Marketing. Against this challenging backdrop, many pharmaceutical companies have stepped up efforts to identify lucrative licensing opportunities as well as apply greater scrutiny to compounds currently in development and how they compare with the competition. "We believe that COMPETITIVE LANDSCAPE will prove to be an invaluable enhancement to the decision-making capabilities of companies competing in the CNS arena, because it will provide them with continually updated information and analysis on the relative competitive positions of hundreds of the most promising CNS compounds."
Assessing the Products and the Players in CNS
Employing a straightforward multi-attribute analytical framework, COMPETITIVE LANDSCAPE evaluates CNS compounds clinically as well as commercially on several key success criteria. Analyses, based on extensive secondary sources, are further shaped by expert insight from Decision Resources' international CNS advisory board and complemented by in-depth interviews with more than 200 thought-leading physicians from around the globe. Outputs of COMPETITIVE LANDSCAPE for CNS compounds include developer company, current development status, mechanism of action, U.S. patent expiry, estimated launch year, clinical and commercial evaluations, forecasted sales, licensing status, and potential licensing opportunities. Assumptions and rationales for all analyses are fully documented. Additionally, "because COMPETITIVE LANDSCAPE focuses on companies as well as compounds, comparisons of companies' current and future CNS franchise strength are readily facilitated," notes Walsh.
Developed with Flexibility and Ease-of-Use in Mind
As a Web site, COMPETITIVE LANDSCAPE provides ready access to valuable information in a user-friendly, "point-and-click" environment. Users can search for specific compounds and companies, and results can be sorted by various criteria for ease of comparison. "A key advantage of COMPETITIVE LANDSCAPE is that clients can customize analyses to examine various 'what-if' scenarios and assess their own compounds against Decision Resources' objective evaluation of the competitive environment," notes Christine Blazynski, Ph.D., Director of New Product Development at Decision Resources. "Tabular results are easily downloaded to Microsoft Excel so that clients can perform such analyses on their desktop in a secure environment. Furthermore, in keeping with Decision Resources' reputation for industry-leading client service and support, subscribers to COMPETITIVE LANDSCAPE can expect thorough and timely responses to individual inquiries and questions."
For more information about how COMPETITIVE LANDSCAPE can help you, please contact:
Joe Walsh, Vice President and Managing Director, North American Sales and Marketing, 781.296.2570, or email@example.com.
Decision Resources, Inc., has been a world leader in CNS market analysis for more than 10 years. The company continues to develop Web-based initiatives in several therapeutic areas to provide its clients immediate access to the most up-to-date information on the ever-changing dynamics of the biopharmaceutical industry. Formerly a subsidiary of Arthur D. Little, Inc., Decision Resources has provided strategic information services to the pharmaceutical and biotechnology industries for 30 years.
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, 888-776-6555 or 212-782-2840
SOURCE: Decision Resources, Inc.
Contact: Joe Walsh, Vice President and Managing Director, North American
Sales and Marketing, of Decision Resources, Inc., +1-781-296-2570,